Literature DB >> 15650354

Immunohistochemical and sequencing analyses of the Wnt signaling components in Japanese anaplastic thyroid cancers.

Takeshi Kurihara1, Satoshi Ikeda, Yasuyo Ishizaki, Masahiko Fujimori, Noriaki Tokumoto, Yuzoh Hirata, Shinji Ozaki, Masazumi Okajima, Keizo Sugino, Toshimasa Asahara.   

Abstract

We investigated the status of the components and target genes of the Wnt signaling pathway in Japanese anaplastic thyroid cancers (ATCs) in the present study. Nuclear and cytoplasmic positive staining of beta-catenin, which might indicate the existence of alterations in the Wnt signaling pathway, were found in 40.9% and 63.6% of the 22 ATC samples, respectively. The beta-catenin, adenomatous polyposis coli (APC) and Axin 1 gene mutations were observed in 4.5%, 9.0%, and 81.8% of the 22 ATC samples, respectively. Overexpression of cyclin D1 and c-myc, which are the target genes of the Wnt signaling pathway, was observed in 27.3% and 59.1% of the ATC samples, respectively. There was no significant correlation between nuclear or cytoplasmic positive staining of beta-catenin and nuclear positive staining of cyclin D1 or c-myc. Taken together, the results of beta-catenin immunohistochemistry suggest that alterations in the Wnt signaling pathway are associated with carcinogenesis of ATC, but the frequency of beta-catenin gene mutation in our series is lower than that previously reported. Furthermore, cyclin D1 and c-myc frequently accumulated in ATC, independently of dysfunction in the Wnt signaling pathway.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15650354     DOI: 10.1089/thy.2004.14.1020

Source DB:  PubMed          Journal:  Thyroid        ISSN: 1050-7256            Impact factor:   6.568


  23 in total

Review 1.  Pax-8-PPAR-γ fusion protein in thyroid carcinoma.

Authors:  Priyadarshini Raman; Ronald J Koenig
Journal:  Nat Rev Endocrinol       Date:  2014-07-29       Impact factor: 43.330

2.  Genomic and transcriptomic hallmarks of poorly differentiated and anaplastic thyroid cancers.

Authors:  Iñigo Landa; Tihana Ibrahimpasic; Laura Boucai; Rileen Sinha; Jeffrey A Knauf; Ronak H Shah; Snjezana Dogan; Julio C Ricarte-Filho; Gnana P Krishnamoorthy; Bin Xu; Nikolaus Schultz; Michael F Berger; Chris Sander; Barry S Taylor; Ronald Ghossein; Ian Ganly; James A Fagin
Journal:  J Clin Invest       Date:  2016-02-15       Impact factor: 14.808

3.  Sorafenib and Quinacrine Target Anti-Apoptotic Protein MCL1: A Poor Prognostic Marker in Anaplastic Thyroid Cancer (ATC).

Authors:  Junaid Abdulghani; Prashanth Gokare; Jean-Nicolas Gallant; David Dicker; Tiffany Whitcomb; Timothy Cooper; Jiangang Liao; Jonathan Derr; Jing Liu; David Goldenberg; Niklas K Finnberg; Wafik S El-Deiry
Journal:  Clin Cancer Res       Date:  2016-06-15       Impact factor: 12.531

Review 4.  Molecular genetics and diagnosis of thyroid cancer.

Authors:  Yuri E Nikiforov; Marina N Nikiforova
Journal:  Nat Rev Endocrinol       Date:  2011-08-30       Impact factor: 43.330

5.  Wnt/beta-Catenin pathway in human glioma: expression pattern and clinical/prognostic correlations.

Authors:  Ce Liu; Yanyang Tu; Xiaoyang Sun; Jian Jiang; Xiaodong Jin; Xiangfei Bo; Zhengming Li; Aimiao Bian; Xiaodong Wang; Dai Liu; Zhengmei Wang; Lianshu Ding
Journal:  Clin Exp Med       Date:  2010-08-31       Impact factor: 3.984

Review 6.  Anaplastic thyroid cancer: molecular pathogenesis and emerging therapies.

Authors:  Robert C Smallridge; Laura A Marlow; John A Copland
Journal:  Endocr Relat Cancer       Date:  2008-11-05       Impact factor: 5.678

Review 7.  Genomic Landscape of poorly Differentiated and Anaplastic Thyroid Carcinoma.

Authors:  Bin Xu; Ronald Ghossein
Journal:  Endocr Pathol       Date:  2016-09       Impact factor: 3.943

Review 8.  Evolving approaches to patients with advanced differentiated thyroid cancer.

Authors:  Bryan R Haugen; Steven I Sherman
Journal:  Endocr Rev       Date:  2013-04-10       Impact factor: 19.871

9.  Characterization of the mutational landscape of anaplastic thyroid cancer via whole-exome sequencing.

Authors:  John W Kunstman; C Christofer Juhlin; Gerald Goh; Taylor C Brown; Adam Stenman; James M Healy; Jill C Rubinstein; Murim Choi; Nimrod Kiss; Carol Nelson-Williams; Shrikant Mane; David L Rimm; Manju L Prasad; Anders Höög; Jan Zedenius; Catharina Larsson; Reju Korah; Richard P Lifton; Tobias Carling
Journal:  Hum Mol Genet       Date:  2015-01-09       Impact factor: 5.121

10.  Recent progress of genome study for anaplastic thyroid cancer.

Authors:  Jieun Lee; Jung-Ah Hwang; Eun Kyung Lee
Journal:  Genomics Inform       Date:  2013-06-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.